Feb 5 (Reuters) - Becton Dickinson ( BDX ) said on
Wednesday its board has authorized a plan to separate its life
sciences unit as the medical device maker aims to focus on its
core business.
(Reporting by Kamal Choudhury, Christy Santhosh and Sriparna
Roy in Bengaluru)